Detalles de la búsqueda
1.
Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia.
Am J Hematol
; 99(4): 759-762, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38314531
2.
Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing.
Mol Cancer
; 14: 89, 2015 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25928096
3.
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.
Leukemia
; 36(7): 1879-1886, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35676453
4.
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission.
Leukemia
; 34(8): 2113-2124, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32472084
5.
Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells.
Leukemia
; 35(8): 2419-2423, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33772144
6.
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase.
J Cancer Res Clin Oncol
; 141(5): 887-99, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25367136
Resultados
1 -
6
de 6
1
Próxima >
>>